Every filing for 35661P100 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
RTW Investments, LP
13G/A
Amendment 1
|
0.7% |
11/16/2026
Event 9/30/2026
|
|
| RTW Investments, LP | 0.7% | ||
| Roderick Wong | 0.7% | ||
|
Perceptive Advisors LLC
13G/A
Amendment 1
|
11.3% |
11/16/2026
Event 9/30/2026
|
|
| Perceptive Advisors LLC | 11.3% | ||
| Joseph Edelman | 11.3% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 11.2% | ||
| C2 Life Sciences LLC | 0.1% | ||
|
ADAR1 Capital Management, LLC
13G/A
Amendment 3
|
1.5% |
11/16/2026
Event 9/30/2026
|
|
| ADAR1 Capital Management, LLC | 1.5% | ||
| ADAR1 Capital Management GP, LLC | 1.3% | ||
| Daniel Schneeberger | 1.5% | ||
|
One Fin Capital Management LP
13G/A
Amendment 2
|
1.1% |
11/16/2026
Event 9/30/2026
|
|
| One Fin Capital Management LP | 1.1% | ||
| One Fin Capital Master Fund LP | 1.1% | ||
| One Fin Capital GP LLC | 1.1% | ||
| David MacKnight | 1.1% | ||
|
Point72 Asset Management, L.P.
13G/A
Amendment 1
|
2.5% |
11/16/2026
Event 9/30/2026
|
|
| Point72 Asset Management, L.P. | 2.5% | ||
| Point72 Capital Advisors, Inc. | 2.5% | ||
| Steven A. Cohen | 2.5% | ||
|
Roche Holdings, Inc.
13G
|
17.4% |
9/1/2026
Event 7/20/2026
|
|
| Roche Holdings, Inc. | 17.4% | ||
| Roche Finance Ltd | 17.4% | ||
| Roche Holding Ltd | 17.4% | ||
|
ADAR1 Capital Management, LLC
13G/A
Amendment 2
|
8.3% |
8/14/2026
Event 6/30/2026
|
|
| ADAR1 Capital Management, LLC | 8.3% | ||
| ADAR1 Capital Management GP, LLC | 6.1% | ||
| Daniel Schneeberger | 8.3% | ||
| Highbridge Capital Management, LLC 13G | 0% |
8/14/2026
Event 6/30/2026
|
|
|
AH Bio Fund I, L.P.
13G
|
5.2% |
7/27/2026
Event 7/20/2026
|
|
| AH Bio Fund I, L.P. | 3.1% | ||
| AH Equity Partners Bio I, L.L.C. | 3.1% | ||
| Andreessen Horowitz LSV Fund II, L.P. | 1.0% | ||
| AH Equity Partners LSV II, L.L.C. | 1.0% | ||
| CLF Partners, LP | 0% | ||
| AH Equity Partners V, L.L.C. | 0% | ||
| AH Parallel Fund IV, L.P. | 1.1% | ||
| AH Equity Partners IV (Parallel), L.L.C. | 1.1% | ||
| Marc L. Andreessen | 5.2% | ||
| Benjamin A. Horowitz | 5.2% | ||
|
Perceptive Advisors LLC
13G
|
10.1% |
7/23/2026
Event 7/20/2026
|
|
| Perceptive Advisors LLC | 10.1% | ||
| Joseph Edelman | 10.1% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 10.1% | ||
|
RA Capital Management, L.P.
13D/A
Amendment 1
|
14.3% |
7/22/2026
Event 7/20/2026
|
|
| RA Capital Management, L.P. | 14.3% | ||
| Peter Kolchinsky | 14.3% | ||
| Rajeev Shah | 14.3% | ||
| RA Capital Healthcare Fund, L.P. | 11.4% |
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 72 | 79.6 M | $1.25B |